# AtriCure CryoICE Lesions for Persistent and Long-standing Persistent Atrial Fibrillation Treatment

> **NCT03732794** · NA · ACTIVE_NOT_RECRUITING · sponsor: **AtriCure, Inc.** · enrollment: 150 (actual)

## Conditions studied

- Atrial Fibrillation (AF)
- Persistent Atrial Fibrillation
- Longstanding Persistent Atrial Fibrillation

## Interventions

- **DEVICE:** AtriCure CryoICE & AtriClip LAA Exclusion

## Key facts

- **NCT ID:** NCT03732794
- **Lead sponsor:** AtriCure, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2019-01-30
- **Primary completion:** 2024-06-27
- **Final completion:** 2026-06
- **Target enrollment:** 150 (ACTUAL)
- **Last updated:** 2024-10-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03732794

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03732794, "AtriCure CryoICE Lesions for Persistent and Long-standing Persistent Atrial Fibrillation Treatment". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03732794. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*